- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Mi | Cannara Biotech is a buy, this analyst says | 1 | Cantech Letter | ||
| 07.04. | Cannara Biotech Inc (2): Cannara Biotech to release fiscal Q2 results April 14 | 1 | Stockwatch | ||
| 07.04. | Stocks in Play: Cannara Biotech Inc. | 1 | Baystreet.ca | ||
| 19.03. | CEO Clips: Video - CEO Clips: Cannara Biotech Graduates to Toronto Stock Exchange | 274 | Newsfile | Vancouver, British Columbia--(Newsfile Corp. - March 19, 2026) - Cannara Biotech Inc. (TSX: LOVE) (OTCQX: LOVFF) (FSE: 8CB0) is a vertically integrated producer of affordable premium-grade cannabis... ► Artikel lesen | |
| 17.03. | Toronto Stock Exchange: Cannara Biotech Inc. (LOVE) Opens the Market | 360 | Newsfile | Toronto, Ontario--(Newsfile Corp. - March 17, 2026) - Donald Olds, Lead Director and Chairman of the Audit and Governance Committee, Cannara Biotech Inc. ("Cannara" or the "Company") (TSX: LOVE)... ► Artikel lesen | |
| CANNARA BIOTECH Aktie jetzt für 0€ handeln | |||||
| 27.02. | Cannara Biotech Inc (2): Cannara receives final OK to transfer shares to TSX | 1 | Stockwatch | ||
| 27.02. | Cannara Biotech Inc (2): Cannara Biotech to delist from TSX-V | 2 | Stockwatch | ||
| 26.02. | Cannara Biotech Inc.: Cannara Announces Graduation to the Toronto Stock Exchange | 214 | GlobeNewswire (Europe) | MONTREAL, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Cannara Biotech Inc. ("Cannara", "the Company", "us" or "we") (TSXV: LOVE) (OTCQX: LOVFF) (FRA: 8CB0), a vertically integrated producer of premium-grade cannabis... ► Artikel lesen | |
| 19.02. | Cannara Biotech Inc (2): Cannara Biotech three-million-share private placement | 4 | Stockwatch | ||
| 13.02. | Cannara Biotech Inc (2): Cannara Biotech to host investor webcast Feb. 19 | 1 | Stockwatch | ||
| 12.02. | Cannara Biotech Inc.: Cannara to Host Investor Webcast on February 19th, 2026 | 1 | GlobeNewswire (USA) | ||
| 04.02. | Cannara Biotech Inc (2): Cannara Biotech closes $6.3-million private placement | 2 | Stockwatch | ||
| 02.02. | Cannara Biotech Q1 2026 slides: Record margins and Quebec market leadership | 3 | Investing.com | ||
| 02.02. | Cannara Biotech überzeugt mit Rekordmargen und Marktführerschaft in Quebec | 2 | Investing.com Deutsch | ||
| 28.01. | Cannara Biotech Inc (2): Cannara receives conditional OK for TSX uplisting | 1 | Stockwatch | ||
| 26.01. | Cannara Biotech: Starkes Wachstum und Marktführerschaft im ersten Quartal 2026 | 2 | Investing.com Deutsch | ||
| 26.01. | Cannara Biotech Inc.: Cannara Reports Q1 Fiscal 2026 Results, Delivers New Record Financial Results, Extends Market Share Gains and Advances Disciplined Expansion Strategy | 286 | GlobeNewswire (Europe) | New Record Financial Results: Total revenues of $30.1 million, gross profit before fair value adjustments of $13.5 million or 45% and Adjusted EBITDA of $8.8 million1, supported by operating cash... ► Artikel lesen | |
| 15.01. | Cannara Biotech Inc (2): Cannara's shares begin trading on OTCQX | 3 | Stockwatch | ||
| 14.01. | Cannara Biotech Inc.: Cannara Achieves OTCQX Qualification and Announces Release of Fiscal Q1 2026 Financial Results on January 26, 2026 | 2 | GlobeNewswire (USA) | ||
| 14.01. | OTC Markets Group Welcomes Cannara Biotech Inc. to OTCQX | 289 | GlobeNewswire (Europe) | NEW YORK, Jan. 14, 2026 (GLOBE NEWSWIRE) -- OTC Markets Group Inc. (OTCQX: OTCM), operator of regulated markets for trading 12,000 U.S. and international securities, today announced Cannara Biotech... ► Artikel lesen |
1 2 Weiter >>
28 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| NOVO NORDISK | 32,180 | -0,05 % | Novo Nordisk: Schon wieder schlechte Nachrichten - was das für die Aktie bedeutet | Die Schlagzeilen rund um Novo Nordisk reißen nicht ab - und erneut sind es negative Nachrichten, die Anleger aufhorchen lassen. Auf den angekündigten Abgang der Top-Forscherin Lotte Bjerre Knudsen reagierte... ► Artikel lesen | |
| AURORA CANNABIS | 3,006 | +0,87 % | Bioxyne unterzeichnet Herstellungsvereinbarung mit globalem Cannabisführer Aurora Cannabis | Die australische Bioxyne Limited (ASX: BXN) ("Bioxyne" oder "das Unternehmen") freut sich, über ihre hundertprozentige
Tochtergesellschaft Breathe Life Sciences (BLS) bekannt zu geben, dass sie... ► Artikel lesen | |
| CANOPY GROWTH | 0,909 | -0,76 % | CANOPY GROWTH CORPORATION: Stabilität als Signal | ||
| STADA ARZNEIMITTEL | - | - | Stada baut interne Kommunikation international aus | ||
| TILRAY BRANDS | 5,710 | -0,35 % | Tilray Brands, Inc.: Tilray Expands Canadian Cannabis Portfolio with Launch of PORTAL, A New High Intensity Brand for the Experienced Consumer | TORONTO, April 08, 2026 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. company (Nasdaq: TLRY; TSX: TLRY) a global lifestyle and consumer packaged goods company at the forefront of the beverage, cannabis... ► Artikel lesen | |
| INNOCAN PHARMA | 3,750 | -3,60 % | KURSZIEL ANGEHOBEN bei InnoCan Pharma: Steht hier der Beginn einer neuen Rally? - Verpassen Sie das nicht | ||
| TAAT GLOBAL ALTERNATIVES | 0,136 | -100,00 % | TAAT Global Alternatives Inc (2): TAAT Global CEO Saxon resigns | ||
| CRONOS GROUP | 2,188 | -0,09 % | Cronos Group Inc.: Cronos Group Reports 2025 Fourth Quarter and Full-Year Results | Net revenue in Q4 2025 increased by 47% year-over-year to $44.5 million; Net revenue in FY 2025 increased by 25% year-over-year to $146.6 million Achieved record net revenue in Q4 2025 and FY 2025... ► Artikel lesen | |
| SYNBIOTIC | 1,886 | -1,87 % | EQS-News: SYNBIOTIC SE: SYNBIOTIC startet mit operativem Fortschritt, neuen regulatorischen Impulsen und starker Branchenpräsenz ins Frühjahr 2026 | EQS-News: SYNBIOTIC SE
/ Schlagwort(e): Marktbericht/Prognose
SYNBIOTIC startet mit operativem Fortschritt, neuen regulatorischen Impulsen und starker Branchenpräsenz ins Frühjahr... ► Artikel lesen | |
| DIGICANN VENTURES | 0,004 | 0,00 % | Digicann Ventures Inc.: Digicann Ventures Announces Resignation of Director | Vancouver, British Columbia--(Newsfile Corp. - April 8, 2026) - Digicann Ventures Ltd. (CSE: DCNN.X) ("Digicann" or the "Company"), a company focused on opportunities within and outside of the cannabis... ► Artikel lesen | |
| ORGANIGRAM GLOBAL | 1,250 | +3,82 % | Organigram Global Inc.: Organigram Announces Shareholder Approval of Acquisition of Sanity Group GmbH and Results of its Annual General and Special Meeting | Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI), (the "Company" or "Organigram"), is pleased to announce that the shareholders of Organigram have overwhelmingly approved the resolution required to... ► Artikel lesen | |
| GREEN THUMB INDUSTRIES | 5,770 | 0,00 % | Green Thumb Industries Inc: Green Thumb releases social impact report | ||
| SNDL | 1,167 | 0,00 % | SNDL Inc.: SNDL Announces Leadership Transition for Cannabis Segment | EDMONTON, Alberta, March 30, 2026 (GLOBE NEWSWIRE) -- SNDL Inc. (NASDAQ: SNDL, CSE: SNDL) ("SNDL" or the "Company") announced today that Tyler Robson, President of Cannabis, has left the Company in... ► Artikel lesen | |
| CRESCO LABS | 0,800 | +0,50 % | Cresco Labs Inc: Cresco Labs opens seventh dispensary in Ohio | ||
| NOVERIS HEALTH SCIENCES | 1,170 | 0,00 % | XFRA 0NF1: AUSSETZUNG/SUSPENSION | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILNOVERIS HEALTH SCI.... ► Artikel lesen |
CANNARA BIOTECH INC gehört der Branche Pharma an. Die relative Kursveränderung beträgt aktuell +7,83 % bei einem Aktienkurs von 1,240 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu CANNARA BIOTECH INC finden Sie auf Wallstreet Online.